Favorite

The COVID-19 pandemic continues to impact every industry around the world, and research is no exception. In fact, research institutions are having to shift and adjust to a new normal while they stabilize their operations and continue vital work. Research in medical, biological, socio-behavioral and many other fields is critical to developing solutions to the pandemic, and consequently, supporting a robust research enterprise has never been more important.

During this podcast series, our experts will address an array of compliance, financial and operational considerations as this industry moves from the triage phase of pandemic management into the stabilization phase, and begin to explore opportunities for fundamental transformation.

The New Normal – Pre-Award Management in the World of COVID-19

In our first podcast of the series, Huron Director Sonia Singh discusses pre-award management in the world of COVID-19 with Huron Associate Aurelio Damiani. Together, they discuss how institutions can adapt during the COVID-19 pandemic and identify new best practices as we stabilize.

Practical Steps for Applying Federal Guidance Revisions for Successful Clinical Research Revenue Cycle Management

In our second podcast of the series, Huron's Nora Yin and Hank LeFlore discuss how providers and research institutions can leverage new guidance from the Centers for Medicare and Medicaid Services (CMS) during the COVID-19 pandemic.

COVID-19 Research Finance Update and Practical Approach to OMB Post-Award Guidance

In our third podcast of the series, Huron's Matthew Faris, Chris Steele and Hank LeFlore discuss the potential financial impacts to institutions conducting research during COVID-19, as well as the Office of Management and Budget's (OMB) recently issued guidance as a result of the ongoing pandemic.

IRBs Dust Off Little-Used Regulatory Pathways for COVID-19 Reviews

In our fourth podcast of the series, Huron's Madeleine Williams and Hank LeFlore discuss how institutional review boards (IRBs) are responding to challenges that have arisen during the COVID-19 pandemic.